Ervin Ukaj is an international executive specializing in digital health innovation, clinical technology, and growth strategy. He currently serves as Chief Executive Officer of Newel Health, a company developing certified, regulator-approved digital therapeutics that extend clinical care for chronic diseases. Under his leadership, Newel Health has advanced a portfolio of software-based medical devices focused on neuroscience, cardiometabolic, and pain management, integrating artificial intelligence and behavioral medicine into everyday clinical practice. Before leading Newel Health, he held senior roles at Novartis, where he managed digital programs across neuroscience, cardiovascular, and ophthalmology. He oversaw the design of digital endpoints for global clinical trials and contributed to the launch strategy of digital therapeutics across the United States, Europe, Japan, and China. Earlier in his career, Ervin Ukaj co-founded and served as Chief Executive Officer of Oppimi Group, a digital therapeutics company active in Canada, Italy, and China. He guided the organization through its international expansion and successful acquisition, positioning Oppimi among the early innovators in AI-driven therapy for learning disabilities. He also held executive roles in Asia with Olicom-PuYing and Wygu Investment Holdings, where he led portfolio strategy, digital transformation, and cross-border partnerships. Ervin Ukaj brings more than fifteen years of experience building and scaling ventures across Europe, North America, and Asia.